Survey of acute renal failure in patients with cystic fibrosis in the UK

Thorax

Volumn 62, Issue 6, 2007, Pages 541-545

  Bertenshaw, Carol ^b   Watson, Alan R ^b   Lewis, Sarah ^a   Smyth, Alan ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AZITHROMYCIN; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; CYCLOSPORIN A; DICLOFENAC; GENTAMICIN; IBUPROFEN; INDOMETACIN; NAPROXEN; RIFAMPICIN; TOBRAMYCIN;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ADOLESCENT; ADULT; ARTICLE; ASTHMA; BRONCHOPULMONARY ASPERGILLOMA; CHILD; COMORBIDITY; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE COURSE; FEMALE; FOLLOW UP; HEALTH SURVEY; HISTOLOGY; HUMAN; HYPERSENSITIVITY REACTION; INFANT; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MALE; PERCEPTION DEAFNESS; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RENAL REPLACEMENT THERAPY; RHEUMATOID ARTHRITIS; RISK FACTOR; TREATMENT DURATION; UNITED KINGDOM;

ACUTE DISEASE; ADOLESCENT; ADULT; AMINOGLYCOSIDES; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; GREAT BRITAIN; HUMANS; INFANT; KIDNEY FAILURE, ACUTE; MALE; RISK FACTORS; TREATMENT OUTCOME;

EID: 34250331071     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2006.067595     Document Type: Article

References (24)

1. Drew J, Watson AR, Smyth A. Acute renal failure and cystic fibrosis. Arch Dis Child 2003;88:646.
2. Drew JH, Watson AR, Evans JHC, et al. Antibiotics and acute renal failure in children with cystic fibrosis. Paediatr Perinat Drug Ther 2002;5:65-7.
3. Kennedy SE, Henry RL, Rosenberg AR. Antibiotic-related renal failure and cystic fibrosis. J Paediatr Child Health 2005;41:382- 3.
4. Stephens SE, Rigden SPA, Price J. Acute renal failure (ARF) in cystic fibrosis patients treated with ceftazidime and gentamicin in combination. Arch Dis Child 2001;84:G169.
5. Bald M, Ratjen F, Nikolaizik W, et al. Ciprofloxacin- induced acute renal failure in a patient with cystic fibrosis. Pediatr Infect Dis J 2001;20:320-1.
6. Moffett BS, Rosenstein BJ, Mogayzel PJ Jr, et al. Ciprofloxacin-induced renal insufficiency in cystic fibrosis. J Cyst Fibros 2003;2:152-4.
7. Kovesi TA, Swartz R, MacDonald N. Transient renal failure due to simultaneous ibupropfen and aminoglycoside therapy in children with cystic fibrosis (letter). N Engl J Med 1998:65-6.
8. Scott CS, Retsch-Bogart GZ, Henry MM. Renal failure and vestibular toxicity in an adolescent with cystic fibrosis receiving gentamicin and standard-dose ibuprofen. Pediatr Pulmonol 2001;31:314-6.
9. Hoffmann IM, Rubin BK, Iskandar SS, et al. Acute renal failure in cystic fibrosis: association with inhaled tobramycin therapy. Pediatr Pulmonol 2002;34:375-7.
10. Desmazes-Dufeu N, Hubert D, Burgel PR, et al. Severe dehydration and August 2003 heat wave in a cohort of adults with cystic fibrosis. Presse Med 2005;34:647-8.
11. Al-Aloul M, Miller H, Stockton P, et al. Acute renal failure in CF patients chronically infected by the Liverpool epidemic Pseudomonas aeruginosa strain (LES). J Cyst Fibros 2005;4:197- 2001.
12. UK Cystic Fibrosis Trust. UK Cystic Fibrosis Database Annual Report 2003. Dundee: University of Dundee, 2005, http://www.cystic-fibrosis. org.uk/pdfs/AnnualReport/AnnualReport2003.pdf.
13. UK Cystic Fibrosis Trust Antibiotic Group. Antibiotic treatment for cystic fibrosis: report of the UK Cystic Fibrosis Trust Antibiotic Group. London: UK Cystic Fibrosis Trust, 2002.
14. British Medical Association, Royal Pharmaceutical Society of Great Britain, Royal College of Paediatrics and Child Health, Neonatal and Paediatric Pharmacists Group. The British National Formulary for Children. London: BMJ Publishing Group, 2005, http://www.nelh.nhs.uk/bnf_children.asp.
15. British Association for Paediatric Nephrology Working Group. The provision of services in the United Kingdom for children and adolescents with renal disease, British Association for Paediatric Nephrology, 1995.
16. Hegarty J, Middleton RJ, Krebs M, et al. Severe acute renal failure in adults: place of care, incidence and outcomes. Q J Med 2005;98:661-6.
17. Stanton BA. Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function. Wien Klin Wochenschr 1997;109:457-64.
18. Al-Aloul M, Miller H, Alapati S, et al. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use. Pediatr Pulmonol 2005;39:15-20.
19. Pitt TL, Sparrow M, Warner M, et al. Survey of resistance of Pseudomonas aeruginosa from UK patients with cystic fibrosis to six commonly prescribed antimicrobial agents. Thorax 2003;58:794-6.
20. Mendelman PM, Smith AL, Levy J, et al. Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum. Am Rev Respir Dis 1985;132:761-5.
21. den Hollander JG, Horrevorts AM, van Goor ML, et al. Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic model. Antimicrob Agents Chemother 1997;41:95-100.
22. Smyth A, Tan KH, Hyman-Taylor P, et al. Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis - the TOPIC study: a randomised controlled trial. Lancet 2005;365:573-8.
23. Smyth A, Tan KH-V, Bunn H. Once daily versus multiple daily dosing with intravenous aminoglycosides for cystic fibrosis. Cochrane Database Syst Rev 2000;(4):CD002009.
24. Anon. Addendum for Antibiotic treatment for Cystic Fibrosis. 2004. 2nd ed. CF Trust, 2002.